Radioimmunotherapy study advances new lymphoma treatment

07/11/2013 | (free registration)

A study published in the Journal of Nuclear Medicine demonstrates the safety and efficacy of radioimmunotherapy using lutetium-177 DOTA rituximab in patients with certain B-cell lymphomas, according to researchers. The clinical trial also revealed that the new treatment option requires less radiation and delivers favorable tumor response.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA